GATC Biotech, LifeCodexx Begin Study of Sequencing-based T21 Test

The firms have begun a validation sudy of the Down syndrome test, which runs on Illumina’s HiSeq platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.